WNT5A and breast cancer: Furthermore, the WNT5A molecule is hydrophobic and has a heparin sulfate-binding domain important for its auto- and paracrine functions that make it less likely that the WNT5A molecule can be used for systemic treatment since it will not reach and target breast cancer cells.